Apellis Pharmaceuticals, Inc.APLSNASDAQ
Loading
Debt to Assets Over TimeElevated
Percentile Rank92
3Y CAGR+45.0%
5Y CAGR+2.8%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
+45.0%/yr
vs +2.8%/yr prior
5Y CAGR
+2.8%/yr
Recent acceleration
Acceleration
+42.3pp
Accelerating
Percentile
P92
Near historical high
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive declineElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.45 | -14.8% |
| 2024 | 0.53 | +277.4% |
| 2023 | 0.14 | -5.1% |
| 2022 | 0.15 | -37.8% |
| 2021 | 0.24 | -39.4% |
| 2020 | 0.39 | -2.5% |
| 2019 | 0.40 | +203.6% |
| 2018 | 0.13 | -8.3% |
| 2017 | 0.14 | - |
| 2016 | 0.00 | - |